| Programme | Time (SGT) |
|---|---|
| MASLD Session Chairs: Prof. Rinaldi Lesmana & Prof. George Goh |
|
| Welcome Address | |
| Debate: Screening at risk patients for NASH – a cost effective strategy in the local context. For: Prof. Chan Wah Kheong View Bio Against: Dr. Yang Wei Lyn View Bio |
|
| Current treatment options, and monitoring response to treatment Prof. George Goh View Bio |
|
| Debunking the myths of dietary intervention in the MASH patient Dr. Mark Cheah View Bio |
|
| Histologic improvement and sustained benefit across hepatic and metabolic biomarkers with pegozafermin therapy: Results from a 48-week multi-center, randomized, double-blind, placebo-controlled Phase 2b trial (ENLIVEN) Dr. Cynthia Hartsfield View Bio |
|
| Q&A | |
| Morning Tea Break | |
| Autoimmune Liver Diseases Session Chairs: Dr. Anand Kulkarni & Prof. Rajender Reddy |
|
| PBC: options for UDCA non-responsive patients Prof. Chan Wah Kheong View Bio |
|
| Difficult to treat Autoimmune Hepatitis Prof. Ajay Duseja View Bio |
|
| Complex Case Discussion Dr. Pei Yiying |
|
| Advanced Liver Disease and Liver Failure Session Chairs: Prof. Simone Strasser & Dr. Rahul Kumar |
|
| Updates in alcohol associated liver disease Dr. Anand V Kulkarni View Bio |
|
| When to use and when not to use albumin Dr. Yogesh Chawla View Bio |
|
| ACLF: From decompensation to acute on chronic liver failure Dr. Rahul Kumar View Bio |
|
| Recompensation of Decompensated Cirrhosis Prof. Rajender Reddy View Bio |
|
| Complex Case Discussion Dr. Qiu Tianyu |
|
| Q&A | |
| Close of Day 1 | |
SHC 2025 Scientific Programme
August, 2025
22
August, 2025
23
| Programme | Time (SGT) |
|---|---|
| HCC Symposium Chairs: Prof. Sakkarin Chirapongsahorn & Dr. Kaina Chen |
|
| Risk stratification in MASLD and viral hepatitis for HCC Prof. Tung Hung Su View Bio |
|
| Novel biomarkers for HCC detection Prof. Amit Singal View Bio |
|
| Artificial intelligence for HCC management Prof. Amit Singal View Bio |
|
| Local Regional and Systemic Combination Therapy for HCC Prof. Pierce Chow View Bio |
|
| Morning Tea Symposium sponsored by Roche – Live in Ballroom 1 & 2 – Live Stream in Ballroom 3 & 4 Innovating Hepatocellular Carcinoma Surveillance with Biomarker-based Algorithm Prof. Henry ChanView Bio |
|
| Immune checkpoint inhibitors and their complications in people with HCC Dr. Anand V Kulkarni View Bio |
|
| Complex Case Discussion Assoc. Prof. Dr. Sakkarin Chirapongsathorn View Bio |
|
| Portal Hypertension Chairs: Dr. Edhel Tripon & Prof. Rajender Reddy |
|
| Debate: Endoscopic Variceal surveillance for Primary Prophylaxis of Variceal Haemorrhage is irrelevant For: Prof. Yogesh Chawla View Bio Against: Prof. Rajender Reddy View Bio |
|
| Non-cirrhotic portal hypertension: diagnosis, management, and transplant considerations Prof. Ajay Duseja View Bio |
|
| Harnessing NIT’s for prevention of variceal bleeding Dr. Wong Yu Jun View Bio |
|
| Afternoon tea symposium sponsored by Novo Nordisk – Live in Ballroom 1 & 2 – Live Stream in Ballroom 3 & 4 From Obesity to Liver disease: Redefining treatment paradigms through metabolic intervention Prof. Rahul Kumar View Bio |
|
| Q&A | |
| Complex Case Discussion Dr. Alyssa Sim |
|
| Close of Singapore Hepatology Conference | |